Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
NZ781070A - Compounds and methods for modulating angiotensinogen expression - Google Patents
[go: Go Back, main page]

NZ781070A - Compounds and methods for modulating angiotensinogen expression - Google Patents

Compounds and methods for modulating angiotensinogen expression

Info

Publication number
NZ781070A
NZ781070A NZ781070A NZ78107016A NZ781070A NZ 781070 A NZ781070 A NZ 781070A NZ 781070 A NZ781070 A NZ 781070A NZ 78107016 A NZ78107016 A NZ 78107016A NZ 781070 A NZ781070 A NZ 781070A
Authority
NZ
New Zealand
Prior art keywords
modulating
compounds
methods
angiotensinogen expression
disorder
Prior art date
Application number
NZ781070A
Inventor
Susan Freier
Mark Graham
Punit P Seth
Adam Mullick
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Publication of NZ781070A publication Critical patent/NZ781070A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed herein are compositions and compounds comprising modified oligonucleotides for modulating AGT and modulating a RAAS pathway related disease, disorder and/or condition in an individual in need thereof. A RAAS pathway related disease, disorder and/or condition in an individual such as hypertension can be treated, ameliorated, delayed or prevented with the administration of antisense compounds targeted to AGT.
NZ781070A 2015-10-08 2016-10-07 Compounds and methods for modulating angiotensinogen expression NZ781070A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562238831P 2015-10-08 2015-10-08
NZ74057616 2016-10-07

Publications (1)

Publication Number Publication Date
NZ781070A true NZ781070A (en) 2024-12-20

Family

ID=94170860

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ781070A NZ781070A (en) 2015-10-08 2016-10-07 Compounds and methods for modulating angiotensinogen expression

Country Status (1)

Country Link
NZ (1) NZ781070A (en)

Similar Documents

Publication Publication Date Title
MX2022005200A (en) Compounds and methods for modulating angiotensinogen expression.
MX2017012426A (en) Compounds and methods for modulating tmprss6 expression.
NZ755605A (en) Compositions for modulating tau expression
MX2020011749A (en) Compositions and methods for modulating pkk expression.
WO2015031679A3 (en) Modulation of prekallikrein (pkk) expression
BR112017003111A2 (en) compositions and methods for the treatment of neurological disorders
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
MX2015012502A (en) Dna-pk inhibitors.
UA117098C2 (en) A COMPOUND CONTAINING MODIFIED OLIGONUCLEOTIDE
PH12014502704B1 (en) Compounds and compositions for modulating egfr activity
MX2020009780A (en) Autotaxin inhibitor compounds.
PH12012502041B1 (en) Method of treating obesity using antioxidant inflammation modulators
JOP20120246B1 (en) COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS
MX2014004074A (en) Methods of treating liver conditions using notch2 antagonists.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
WO2013106460A3 (en) Compositions and methods for treating malignant astrocytomas
NZ781070A (en) Compounds and methods for modulating angiotensinogen expression
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
PH12020500472A1 (en) Autotaxin inhibitor compounds
MX2016005808A (en) Compositions and methods for the treatment of viral diseases with pde4 modulators.
TN2014000401A1 (en) Microrna compounds and methods for modulating mir-21 activity

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 OCT 2026 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS

Effective date: 20250821